CLINICAL_TRIALS
trial_result
· 2012-08-21
Clinical Trial Update: Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®
Summary
Non-interventional (observational) study in patients with advanced or metastatic renal cell carcinoma treated with SUTENT (sorafenib) completed with results pos…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Metastatic Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2012-08-21